ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC
Durvalumab addition to chemo shows endometrial cancer benefit
Adagrasib pembrolizumab combo shows promise for KRASG12C-positive NSCLC
Selpercatinib benefit for advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer
CheckMate-77T: Perioperative nivolumab benefit for NSCLC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
McVie-Veronesi Awards: 2nd prize - Harnessing artificial intelligence to mitigate depression rates in cancer clinicians
McVie-Veronesi awards: 1st Prize - Insights into journeys of cancer patients in India - Access, affordability and barriers
McVie-Veronesi awards: Case reports on struma ovarii
McVie-Veronesi Awards: Molecular detection of circulating types of human papillomavirus infection in West Bengal
McVie-Veronesi Awards: 3rd Prize - Role of sentinel lymph node biopsy in node positive breast cancer patients? Converting to node negativity after neoadjuvant chemotherapy
McVie-Veronesi Awards:Harnessing machine learning to create predictive models in mitigating disease states